Eleftha Trastuzumab Emtansine 375 mg Injection
Eleftha Trastuzumab Emtansine 375 mg Injection is an advanced targeted anti-cancer medication used in the treatment of HER2-positive breast cancer. It combines the monoclonal antibody Trastuzumab Emtansine with a cytotoxic agent (DM1), allowing direct delivery of chemotherapy to cancer cells while minimizing damage to healthy tissues.
This innovative antibody-drug conjugate (ADC) works by specifically targeting HER2 receptors present on cancer cells, binding to them, and releasing the chemotherapy agent inside the tumor cell. This targeted approach enhances treatment effectiveness and reduces systemic side effects compared to traditional chemotherapy.
📞 Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
🌐 Website: https://globmedindia.com
Composition and Content
Active Ingredient: Trastuzumab Emtansine
Strength: 375 mg per vial
Form: Lyophilized powder for intravenous infusion
Class: Antibody-Drug Conjugate (ADC)
Uses of Eleftha Trastuzumab Emtansine Injection
Treatment of HER2-positive metastatic breast cancer
Used in patients previously treated with trastuzumab and taxane-based chemotherapy
Adjuvant therapy for residual invasive breast cancer after neoadjuvant treatment
How It Works
Eleftha binds to HER2 receptors on cancer cells and delivers a potent cytotoxic agent directly inside the cell. This:
Stops cancer cell growth
Induces apoptosis (cell death)
Minimizes damage to normal cells
Advantages
✔ Targeted therapy with higher precision
✔ Reduced systemic toxicity compared to conventional chemotherapy
✔ Improved progression-free survival rates
✔ Convenient dosing schedule (usually every 3 weeks)
✔ Effective in resistant HER2-positive breast cancer cases
Dosage & Administration
Administered via intravenous infusion
Typical dose: 3.6 mg/kg body weight every 3 weeks
Must be given under supervision of an oncologist
Dose adjustments may be required based on patient response and side effects
Storage Conditions
Store at 2°C to 8°C (refrigerated)
Do not freeze
Protect from light
Keep in original packaging until use
Use reconstituted solution immediately or as directed
Alternate Indian Brands for Trastuzumab Emtansine
Kadcyla (by Roche)
Vivitra (Trastuzumab Emtansine variants available in India)
Other biosimilar HER2-targeted therapies may be prescribed based on availability
Buy Eleftha Trastuzumab Emtansine 375 mg Injection Online – GlobMedIndia
Looking for a reliable global supplier of advanced anti-cancer medicines? GlobMedIndia – The Medicine Exporter offers genuine Eleftha Trastuzumab Emtansine 375 mg Injection with assured quality, competitive pricing, and fast international delivery.
We specialize in exporting life-saving oncology medicines to countries including the United States, United Kingdom, United Arab Emirates, Australia, Japan, South Korea, Thailand, Vietnam, Indonesia, China, Russia, Ukraine, Morocco, Ethiopia, Romania, Chile, Peru, and across Europe, the Middle East, Africa, and Southeast Asia.
We also deliver to major cities like London, Cambridge, and Dubai with secure packaging and temperature-controlled logistics.
Why Choose GlobMedIndia?
✔ 100% genuine oncology medicines
✔ Competitive export pricing
✔ Fast & safe international delivery
✔ Temperature-controlled shipping
✔ Trusted by global patients and healthcare providers
Eleftha Trastuzumab Emtansine 375 mg Injection
Buy Trastuzumab Emtansine online India
HER2 breast cancer targeted therapy
Kadcyla alternative India
Anti-cancer medicine exporter India
GlobMedIndia oncology medicines
Trastuzumab Emtansine price India
Buy Kadcyla biosimilar online
Cancer injection supplier worldwide
HER2 positive breast cancer treatment drugs
Conclusion
Eleftha Trastuzumab Emtansine 375 mg Injection is a highly effective targeted therapy for HER2-positive breast cancer, offering improved outcomes with fewer side effects. With GlobMedIndia, patients worldwide can access this life-saving medication with fast, reliable, and secure delivery.
